Advertisement

Topics

FDA approves new fluoroquinolone antibiotic to treat bacterial skin infections

08:16 EDT 20 Jun 2017 | thePharmaLetter

The US Food and Drug Administration on Monday approved Baxdela (delafloxacin), a new antibacterial drug

Original Article: FDA approves new fluoroquinolone antibiotic to treat bacterial skin infections

NEXT ARTICLE

More From BioPortfolio on "FDA approves new fluoroquinolone antibiotic to treat bacterial skin infections"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...